Yue‐Zhong Shu

Metabolic and Pharmaceutical Aspects of Fluorinated Compounds

Benjamin M. Johnson, Yue‐Zhong Shu, Xiaoliang Zhuo et al. · Journal of Medicinal Chemistry · 2020 · 633 citations · Full text

Stephacidin A and B:  Two Structurally Novel, Selective Inhibitors of the Testosterone-Dependent Prostate LNCaP Cells

Jingfang Qian‐Cutrone, Stella Huang, Yue‐Zhong Shu et al. · Journal of the American Chemical Society · 2002 · 221 citations

Secondary Metabolite, Selective Inhibitors, Pharmacotherapy +19

Metabolism of paeoniflorin and related compounds by human intestinal bacteria.

Masao Hattori, Yue‐Zhong Shu, Mineo Shimizu et al. · Chemical and Pharmaceutical Bulletin · 1985 · 83 citations · Full text

Microbial Physiology, Secondary Metabolite, Digestive Tract +16

Studies on dental caries prevention by traditional medicines. X Antibacterial action of phenolic components from mace against Streptococcus mutans.

Masao Hattori, SUMITRA HADA, Akiko Watahiki et al. · Chemical and Pharmaceutical Bulletin · 1986 · 69 citations · Full text

Oral Microbiology, Preventive Dentistry, Dental Infections +18

A Strategy to Minimize Reactive Metabolite Formation: Discovery of (<i>S</i>)-4-(1-Cyclopropyl-2-methoxyethyl)-6-[6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino]-5-oxo-4,5-dihydropyrazine-2-carbonitrile as a Potent, Orally Bioavailable Corticotropin-Releasing Factor-1 Receptor Antagonist

Richard A. Hartz, Vijay T. Ahuja, Xiaoliang Zhuo et al. · Journal of Medicinal Chemistry · 2009 · 54 citations · Full text

Pharmaceutical Science, Metabolic Characterization, Receptor Antagonist +16